RHÖN-KLINIKUM AG Reports Robust Q3 2025 Financial Performance

In the third quarter of 2025, RHÖN-KLINIKUM AG reported a revenue increase of 7.8%, reaching EUR 1,262.1 million, attributable to a 2.5% rise in patient numbers. Despite these gains, EBITDA decreased slightly to EUR 71.8 million, influenced by the cessation of legislative relief on energy costs and challenges in cost management.

The consolidated profit for the period was EUR 25.1 million, reflecting a stable equity ratio of 71.9%. The healthcare provider navigates a challenging financial landscape, impacted by geopolitical tensions, cost pressures, and hospital sector reforms in Germany.

The management remains committed to a sustainable approach amidst this backdrop. Looking forward, RHÖN-KLINIKUM AG projects annual revenues of EUR 1.7 billion and an EBITDA range of EUR 110 to 125 million, recognizing the potential impact of global economic uncertainties.